...
首页> 外文期刊>Tissue engineering, Part A >Functional Tissue Engineering: A Prevascularized Cardiac Muscle Construct for Validating Human Mesenchymal Stem Cells Engraftment Potential In Vitro
【24h】

Functional Tissue Engineering: A Prevascularized Cardiac Muscle Construct for Validating Human Mesenchymal Stem Cells Engraftment Potential In Vitro

机译:功能组织工程:一种血糖化心肌构建体,用于在体外验证人间充质干细胞植入潜力

获取原文
获取原文并翻译 | 示例
           

摘要

The influence of somatic stem cells in the stimulation of mammalian cardiac muscle regeneration is still in its early stages, and so far, it has been difficult to determine the efficacy of the procedures that have been employed. The outstanding question remains whether stem cells derived from the bone marrow or some other location within or outside of the heart can populate a region of myocardial damage and transform into tissue-specific differentiated progenies, and also exhibit functional synchronization. Consequently, this necessitates the development of an appropriate in vitro three-dimensional (3D) model of cardiomyogenesis and prompts the development of a 3D cardiac muscle construct for tissue engineering purposes, especially using the somatic stem cell, human mesenchymal stem cells (hMSCs). To this end, we have created an in vitro 3D functional prevascularized cardiac muscle construct using embryonic cardiac myocytes (eCMs) and hMSCs. First, to generate the prevascularized scaffold, human cardiac microvascular endothelial cells (hCMVECs) and hMSCs were cocultured onto a 3D collagen cell carrier (CCC) for 7 days under vasculogenic culture conditions; hCMVECs/hMSCs underwent maturation, differentiation, and morphogenesis characteristic of microvessels, and formed dense vascular networks. Next, the eCMs and hMSCs were cocultured onto this generated prevascularized CCCs for further 7 or 14 days in myogenic culture conditions. Finally, the vascular and cardiac phenotypic inductions were characterized at the morphological, immunological, biochemical, molecular, and functional levels. Expression and functional analyses of the differentiated progenies revealed neo-cardiomyogenesis and neo-vasculogenesis. In this milieu, for instance, not only were hMSCs able to couple electromechanically with developing eCMs but were also able to contribute to the developing vasculature as mural cells, respectively. Hence, our unique 3D coculture system provides us a reproducible and quintessential in vitro 3D model of cardiomyogenesis and a functioning prevascularized 3D cardiac graft that can be utilized for personalized medicine.
机译:体细胞干细胞在哺乳动物心肌再生刺激中的影响仍处于早期阶段,到目前为止,难以确定所用程序的疗效。突出的问题仍然是源自骨髓或内外的一些其他位置的干细胞是否可以填充心肌损伤的区域并转化为组织特异性分化的后,并且还表现出功能性同步。因此,这需要开发适当的体外三维(3D)模型的心肌发生模型,并促使用于组织工程目的的3D心肌构建体的发展,特别是使用体细胞干细胞,人间充质干细胞(HMSCs)。为此,我们使用胚胎心肌细胞(ECMS)和HMSCs创造了一种体外3D功能性心血塑肌肉构建体。首先,为了产生血糖化的支架,在血管原性培养条件下将人心脏微血管内皮细胞(HCMVEC)和HMSC分类在3D胶原细胞载体(CCC)上进行7天; HCMVECS / HMSCs经历了微血管的成熟,分化和形态发生特征,并形成了致密的血管网络。接下来,将ECM和HMSC分类在肌遗传培养条件下进一步7或14天内生成的患病的CCC。最后,血管和心脏表型诱导的特征在于形态学,免疫,生物化学,分子和功能水平。差异化后代的表达和功能分析显示了新心肌发生和新血管生成。例如,在这个Milieu中,不仅可以通过显影ECMS机电耦合的HMSC,但也能够分别为显影脉管系统贡献作为壁球菌。因此,我们独特的3D共培养系统为我们提供了一种可重复和典型的体外3D模型的心肌细胞和功能性,其可用于个性化药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号